These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7273030)

  • 1. Dianhydrogalactitol in the treatment of children with primary brain tumors.
    Weinblatt ME; Ortega JA; Giggins GR; Siegel SE
    Cancer Treat Rep; 1981; 65(9-10):923-4. PubMed ID: 7273030
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II clinical trial of dianhydrogalactitol for remission induction in children with acute leukemia: a Southwest Oncology Group Study.
    Vats TS; Lui V; Trueworthy R; van Eys J
    Cancer Treat Rep; 1981; 65(1-2):121-2. PubMed ID: 6939482
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II trial of dianhydrogalactitol in the treatment of children with refractory childhood malignancies: a report from the Children's Cancer Study Group.
    Finklestein JZ; Shore N; Krivit W; Hammond D; Higgins G
    Cancer Treat Rep; 1985 Nov; 69(11):1331-3. PubMed ID: 4092198
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II studies of dianhydrogalactitol-based combination chemotherapy for recurrent brain tumors.
    Eagan RT; Creagan ET; Bisel HF; Layton DD; Groover RV; Herman RC
    Oncology; 1981; 38(1):4-6. PubMed ID: 7443176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dianhydrogalactitol and radiation therapy. Treatment of supratentorial glioma.
    Eagan RT; Childs DS; Layton DD; Laws ER; Bisel HF; Holbrook MA; Fleming TR
    JAMA; 1979 May; 241(19):2046-50. PubMed ID: 219269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of dianhydrogalactitol in advanced soft tissue and bony sarcomas: a Southwest Oncology Group study.
    Thigpen JT; Samson MK
    Cancer Treat Rep; 1979 Apr; 63(4):553-5. PubMed ID: 445509
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II study of dianhydrogalactitol in malignant glioma.
    Espana P; Wiernik PH; Walker MD
    Cancer Treat Rep; 1978 Aug; 62(8):1199-200. PubMed ID: 210944
    [No Abstract]   [Full Text] [Related]  

  • 8. Dianhydrogalactitol (NSC-132313): phase II study in solid tumors.
    de Jager R; Brugarolas A; Hansen H; Cavalli F; Ryssel H; Siegenthaler P; Clarysse A; Renard J; Kenis Y; Alberto P
    Eur J Cancer (1965); 1979 Jul; 15(7):971-4. PubMed ID: 385328
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination carmustine (BCNU) and dianhydrogalactitol in the treatment of primary brain tumors recurring after irradiation.
    Eagan RT; Dinapoli RP; Hermann RC; Groover RV; Layton DD; Scott M
    Cancer Treat Rep; 1982 Aug; 66(8):1647-9. PubMed ID: 7105055
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II evaluation of dianhydrogalactitol in lung cancer: a Southwest Oncology Group Study.
    Haas CD; Baker L; Thigpen T
    Cancer Treat Rep; 1981; 65(1-2):115-7. PubMed ID: 6261943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical observation of 15 cases of chronic myelogenous leukemia treated with 1,2,5,6-dianhydrodulcitol].
    Huang ZG
    Zhonghua Nei Ke Za Zhi; 1982 Jun; 21(6):356-8. PubMed ID: 6957285
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II study of single-agent therapy with megestrol acetate, VP-16-213, cyclophosphamide, and dianhydrogalactitol in advanced renal cell cancer.
    Hahn RG; Bauer M; Wolter J; Creech R; Bennett JM; Wampler G
    Cancer Treat Rep; 1979 Mar; 63(3):513-5. PubMed ID: 371804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II evaluation of dianhydrogalactitol in the treatment of advanced endometrial adenocarcinoma: a Gynecologic Oncology Group Study.
    Stehman FB; Blessing JA; Delgado G; Louka M
    Cancer Treat Rep; 1983; 67(7-8):737-8. PubMed ID: 6871892
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II evaluation of dianhydrogalactitol in the treatment of advanced non-squamous cervical carcinoma. A Gynecologic Oncology Group study.
    Stehman FB; Blessing JA; Homesley HD; Currie JL; Yordan EL
    Invest New Drugs; 1984; 2(3):331-3. PubMed ID: 6511240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of dianhydrogalactitol in advanced renal cell carcinoma: a Southwest Oncology Group study.
    Ratanatharathorn V; Baker LH; Balducci L; Talley RW; Hoogstraten B
    Cancer Treat Rep; 1982 May; 66(5):1231-2. PubMed ID: 7083224
    [No Abstract]   [Full Text] [Related]  

  • 16. In vivo synchronization and cell kinetics-directed treatment scheduled in human tumor therapy.
    Barranco SC; Townsend CM; Costanzi JJ; Guseman LF
    Prog Clin Biol Res; 1983; 132C():163-70. PubMed ID: 6634770
    [No Abstract]   [Full Text] [Related]  

  • 17. Dianhydrogalactitol and neural tumors: an in vitro, in vivo preclinical evaluation.
    Helson L; Rozsa P; Hajdu E; Helson JL
    Cancer Treat Rep; 1980; 64(12):1287-94. PubMed ID: 7471118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II evaluation of galactitol in head and neck cancer: a Southwest Oncology Group Study.
    Haas CD; Lehane D; Bottomley R
    Med Pediatr Oncol; 1983; 11(4):281-3. PubMed ID: 6888328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapeutic approaches to brain tumors. Experimental observations with dianhydrogalactitol and dibromodulcitol.
    Levin VA; Wheeler KT
    Cancer Chemother Pharmacol; 1982; 8(1):125-31. PubMed ID: 7094198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of 1,2:5,6-dianhydrogalactitol in studies on cell kinetics-directed chemotherapy schedules in human tumors in vivo.
    Barranco SC; Townsend CM; Costanzi JJ; May JT; Baltz R; O'Quinn AG; Leipzig B; Hokanson KM; Guseman LF; Boerwinkle WR
    Cancer Res; 1982 Jul; 42(7):2899-2905. PubMed ID: 7083178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.